Damian J. Green

γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma

Margot J. Pont, Tyler Hill, Gabriel O. Cole et al. · Blood · 2019 · 310 citations · Full text

Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies

Jordan Gauthier, Evandro D. Bezerra, Alexandre V. Hirayama et al. · Blood · 2020 · 204 citations · Full text

Fully Human Bcma Targeted Chimeric Antigen Receptor T Cells Administered in a Defined Composition Demonstrate Potency at Low Doses in Advanced Stage High Risk Multiple Myeloma

Damian J. Green, Margot J. Pont, Blythe Sather et al. · Blood · 2018 · 129 citations

Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy

Nicolas Gazeau, Emily C. Liang, Qian Wu et al. · Transplantation and Cellular Therapy · 2023 · 114 citations · Full text

Inflammation, Autoimmune Disease, Medicine +10

γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial

Andrew J. Cowan, Margot J. Pont, Blythe Sather et al. · The Lancet Oncology · 2023 · 87 citations · Full text

Hematological Malignancy, Cancer Immunosurveillance, Immunology +10